Clinical Trial Update: Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating tirzepatide for weight loss and chronic inflammation in people with HIV; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Inflammation
• Obesity

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: University of Hawaii | Conditions: Obesity and Overweight, HIV | Phase 2 | Status: RECRUITING